Independent Medical Education
At GSK, we are finding new independent and transparent ways to support healthcare professional education in Ireland.
What does this look like?
Outcome driven: We want to support education initiatives with clear, measurable outcomes so that the benefit to patients is measurable and demonstrable.
Patient Focused: We also want to concentrate on disease areas in which there is a genuine patient need and in which we have a mutual scientific interest.
Arms-length: We have no involvement or influence on the education development, logistics or participant selection.
Need: We focus our financial resource on programmes that have the greatest potential to enable people to do more, feel better and live longer
Why GSK supports medical education?
Supporting medical education has always and continues to be very important part of what we do at GSK. The healthcare professionals who prescribe the medicines we develop are an integral part of a patient journey. Healthcare, particularly medicine, is an innovative and fast evolving area. We want to support healthcare professionals in ensuring they can access high quality, up to date medical education to help them make the best decisions for their patients.
At GSK, we have changed how we support HCPs: instead of directly funding healthcare professionals, we are finding new, more independent ways to do this. These changes do not affect our commitment to medical education but instead mean the decisions about ‘what’, ‘how’ and ‘who’ are made by independent organisations and not by GSK. It is very important that this support exists, particularly in a healthcare system under severe resource constraints. But we believe it is equally important that this is done transparently and free from perceptions of any potential conflicts of interest. The combination of HCP and patient confidence in healthcare plays a critical role in how patients feel and how they respond to treatment so it is very important that these relationships are based on trust.
Applications for IME are currently open. The closing date for submissions is Friday 11 October, 2019.
Decisions on funding requests will be made within 4 weeks following the submission deadline.
Any Further Assistance:
Mail: Business Support Executive. GlaxoSmithKline Ireland Ltd, Citywest business Campus, 12 River Walk, Dublin 24.